Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005654 | nucleoplasm | 2 | 2 |
GO:0005681 | spliceosomal complex | 3 | 2 |
GO:0005684 | U2-type spliceosomal complex | 4 | 2 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0032991 | protein-containing complex | 1 | 2 |
GO:0071006 | U2-type catalytic step 1 spliceosome | 4 | 2 |
GO:0071012 | catalytic step 1 spliceosome | 3 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0140513 | nuclear protein-containing complex | 2 | 2 |
GO:1902494 | catalytic complex | 2 | 2 |
GO:1990904 | ribonucleoprotein complex | 2 | 2 |
Related structures:
AlphaFold database: E9ADY0
Term | Name | Level | Count |
---|---|---|---|
GO:0000375 | RNA splicing, via transesterification reactions | 8 | 7 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 9 | 7 |
GO:0000398 | mRNA splicing, via spliceosome | 8 | 7 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 7 |
GO:0006396 | RNA processing | 6 | 7 |
GO:0006397 | mRNA processing | 7 | 7 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 7 |
GO:0006807 | nitrogen compound metabolic process | 2 | 7 |
GO:0008152 | metabolic process | 1 | 7 |
GO:0008380 | RNA splicing | 7 | 7 |
GO:0009987 | cellular process | 1 | 7 |
GO:0016070 | RNA metabolic process | 5 | 7 |
GO:0016071 | mRNA metabolic process | 6 | 7 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 7 |
GO:0043170 | macromolecule metabolic process | 3 | 7 |
GO:0044237 | cellular metabolic process | 2 | 7 |
GO:0044238 | primary metabolic process | 2 | 7 |
GO:0046483 | heterocycle metabolic process | 3 | 7 |
GO:0071704 | organic substance metabolic process | 2 | 7 |
GO:0090304 | nucleic acid metabolic process | 4 | 7 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 387 | 391 | PF00656 | 0.694 |
CLV_C14_Caspase3-7 | 394 | 398 | PF00656 | 0.771 |
CLV_NRD_NRD_1 | 20 | 22 | PF00675 | 0.411 |
CLV_NRD_NRD_1 | 203 | 205 | PF00675 | 0.381 |
CLV_NRD_NRD_1 | 286 | 288 | PF00675 | 0.411 |
CLV_NRD_NRD_1 | 321 | 323 | PF00675 | 0.386 |
CLV_NRD_NRD_1 | 331 | 333 | PF00675 | 0.396 |
CLV_NRD_NRD_1 | 34 | 36 | PF00675 | 0.411 |
CLV_NRD_NRD_1 | 455 | 457 | PF00675 | 0.792 |
CLV_NRD_NRD_1 | 464 | 466 | PF00675 | 0.695 |
CLV_NRD_NRD_1 | 66 | 68 | PF00675 | 0.411 |
CLV_NRD_NRD_1 | 78 | 80 | PF00675 | 0.411 |
CLV_PCSK_FUR_1 | 201 | 205 | PF00082 | 0.381 |
CLV_PCSK_FUR_1 | 32 | 36 | PF00082 | 0.411 |
CLV_PCSK_KEX2_1 | 127 | 129 | PF00082 | 0.372 |
CLV_PCSK_KEX2_1 | 203 | 205 | PF00082 | 0.381 |
CLV_PCSK_KEX2_1 | 286 | 288 | PF00082 | 0.411 |
CLV_PCSK_KEX2_1 | 321 | 323 | PF00082 | 0.409 |
CLV_PCSK_KEX2_1 | 331 | 333 | PF00082 | 0.416 |
CLV_PCSK_KEX2_1 | 34 | 36 | PF00082 | 0.411 |
CLV_PCSK_KEX2_1 | 464 | 466 | PF00082 | 0.768 |
CLV_PCSK_KEX2_1 | 49 | 51 | PF00082 | 0.411 |
CLV_PCSK_KEX2_1 | 66 | 68 | PF00082 | 0.411 |
CLV_PCSK_KEX2_1 | 78 | 80 | PF00082 | 0.411 |
CLV_PCSK_KEX2_1 | 83 | 85 | PF00082 | 0.411 |
CLV_PCSK_PC1ET2_1 | 127 | 129 | PF00082 | 0.385 |
CLV_PCSK_PC1ET2_1 | 34 | 36 | PF00082 | 0.411 |
CLV_PCSK_PC1ET2_1 | 49 | 51 | PF00082 | 0.411 |
CLV_PCSK_PC1ET2_1 | 83 | 85 | PF00082 | 0.513 |
CLV_PCSK_PC7_1 | 199 | 205 | PF00082 | 0.363 |
CLV_PCSK_PC7_1 | 79 | 85 | PF00082 | 0.513 |
CLV_PCSK_SKI1_1 | 321 | 325 | PF00082 | 0.411 |
CLV_PCSK_SKI1_1 | 78 | 82 | PF00082 | 0.375 |
DEG_SCF_FBW7_1 | 111 | 117 | PF00400 | 0.411 |
DEG_SCF_FBW7_1 | 360 | 365 | PF00400 | 0.705 |
DEG_SPOP_SBC_1 | 227 | 231 | PF00917 | 0.513 |
DEG_SPOP_SBC_1 | 239 | 243 | PF00917 | 0.183 |
DEG_SPOP_SBC_1 | 309 | 313 | PF00917 | 0.280 |
DEG_SPOP_SBC_1 | 362 | 366 | PF00917 | 0.728 |
DOC_CKS1_1 | 111 | 116 | PF01111 | 0.411 |
DOC_CYCLIN_yCln2_LP_2 | 351 | 357 | PF00134 | 0.397 |
DOC_MAPK_gen_1 | 405 | 412 | PF00069 | 0.560 |
DOC_MAPK_gen_1 | 49 | 57 | PF00069 | 0.411 |
DOC_MAPK_gen_1 | 83 | 91 | PF00069 | 0.513 |
DOC_PP2B_LxvP_1 | 351 | 354 | PF13499 | 0.397 |
DOC_PP4_FxxP_1 | 247 | 250 | PF00568 | 0.411 |
DOC_PP4_FxxP_1 | 442 | 445 | PF00568 | 0.809 |
DOC_PP4_FxxP_1 | 53 | 56 | PF00568 | 0.367 |
DOC_USP7_MATH_1 | 218 | 222 | PF00917 | 0.496 |
DOC_USP7_MATH_1 | 240 | 244 | PF00917 | 0.436 |
DOC_USP7_MATH_1 | 355 | 359 | PF00917 | 0.411 |
DOC_USP7_MATH_1 | 372 | 376 | PF00917 | 0.710 |
DOC_USP7_MATH_1 | 398 | 402 | PF00917 | 0.769 |
DOC_USP7_MATH_1 | 446 | 450 | PF00917 | 0.716 |
DOC_USP7_MATH_1 | 69 | 73 | PF00917 | 0.353 |
DOC_USP7_UBL2_3 | 374 | 378 | PF12436 | 0.702 |
DOC_WW_Pin1_4 | 110 | 115 | PF00397 | 0.411 |
DOC_WW_Pin1_4 | 235 | 240 | PF00397 | 0.471 |
DOC_WW_Pin1_4 | 310 | 315 | PF00397 | 0.280 |
DOC_WW_Pin1_4 | 358 | 363 | PF00397 | 0.765 |
LIG_14-3-3_CanoR_1 | 286 | 292 | PF00244 | 0.474 |
LIG_14-3-3_CanoR_1 | 421 | 428 | PF00244 | 0.736 |
LIG_14-3-3_CanoR_1 | 50 | 54 | PF00244 | 0.390 |
LIG_14-3-3_CanoR_1 | 78 | 86 | PF00244 | 0.375 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.624 |
LIG_BRCT_BRCA1_1 | 243 | 247 | PF00533 | 0.513 |
LIG_FHA_1 | 337 | 343 | PF00498 | 0.459 |
LIG_FHA_1 | 421 | 427 | PF00498 | 0.742 |
LIG_FHA_1 | 50 | 56 | PF00498 | 0.353 |
LIG_FHA_2 | 107 | 113 | PF00498 | 0.411 |
LIG_FHA_2 | 229 | 235 | PF00498 | 0.513 |
LIG_FHA_2 | 305 | 311 | PF00498 | 0.319 |
LIG_LIR_Apic_2 | 10 | 16 | PF02991 | 0.355 |
LIG_LIR_Apic_2 | 244 | 250 | PF02991 | 0.513 |
LIG_LIR_Apic_2 | 440 | 445 | PF02991 | 0.805 |
LIG_LIR_Apic_2 | 52 | 56 | PF02991 | 0.411 |
LIG_LIR_Nem_3 | 130 | 136 | PF02991 | 0.411 |
LIG_LIR_Nem_3 | 17 | 23 | PF02991 | 0.411 |
LIG_LIR_Nem_3 | 274 | 280 | PF02991 | 0.411 |
LIG_LIR_Nem_3 | 285 | 291 | PF02991 | 0.411 |
LIG_PCNA_yPIPBox_3 | 317 | 331 | PF02747 | 0.261 |
LIG_Pex14_2 | 53 | 57 | PF04695 | 0.411 |
LIG_SH2_GRB2like | 75 | 78 | PF00017 | 0.411 |
LIG_SH2_PTP2 | 13 | 16 | PF00017 | 0.411 |
LIG_SH2_SRC | 85 | 88 | PF00017 | 0.375 |
LIG_SH2_STAT5 | 106 | 109 | PF00017 | 0.416 |
LIG_SH2_STAT5 | 120 | 123 | PF00017 | 0.411 |
LIG_SH2_STAT5 | 13 | 16 | PF00017 | 0.411 |
LIG_SH2_STAT5 | 85 | 88 | PF00017 | 0.411 |
LIG_SH3_1 | 108 | 114 | PF00018 | 0.411 |
LIG_SH3_2 | 451 | 456 | PF14604 | 0.690 |
LIG_SH3_3 | 108 | 114 | PF00018 | 0.411 |
LIG_SH3_3 | 342 | 348 | PF00018 | 0.311 |
LIG_SH3_3 | 403 | 409 | PF00018 | 0.808 |
LIG_SH3_3 | 448 | 454 | PF00018 | 0.762 |
LIG_SH3_CIN85_PxpxPR_1 | 451 | 456 | PF14604 | 0.768 |
LIG_SUMO_SIM_anti_2 | 399 | 404 | PF11976 | 0.576 |
LIG_SUMO_SIM_anti_2 | 93 | 98 | PF11976 | 0.411 |
LIG_TRAF2_1 | 143 | 146 | PF00917 | 0.407 |
LIG_TRAF2_1 | 182 | 185 | PF00917 | 0.513 |
LIG_WW_3 | 453 | 457 | PF00397 | 0.686 |
MOD_CDK_SPK_2 | 110 | 115 | PF00069 | 0.411 |
MOD_CK1_1 | 221 | 227 | PF00069 | 0.468 |
MOD_CK1_1 | 238 | 244 | PF00069 | 0.315 |
MOD_CK1_1 | 358 | 364 | PF00069 | 0.775 |
MOD_CK1_1 | 401 | 407 | PF00069 | 0.777 |
MOD_CK1_1 | 424 | 430 | PF00069 | 0.699 |
MOD_CK2_1 | 106 | 112 | PF00069 | 0.411 |
MOD_CK2_1 | 228 | 234 | PF00069 | 0.513 |
MOD_CK2_1 | 261 | 267 | PF00069 | 0.449 |
MOD_CK2_1 | 304 | 310 | PF00069 | 0.397 |
MOD_Cter_Amidation | 32 | 35 | PF01082 | 0.411 |
MOD_GlcNHglycan | 219 | 223 | PF01048 | 0.429 |
MOD_GlcNHglycan | 263 | 266 | PF01048 | 0.482 |
MOD_GlcNHglycan | 355 | 358 | PF01048 | 0.490 |
MOD_GlcNHglycan | 365 | 368 | PF01048 | 0.673 |
MOD_GlcNHglycan | 423 | 426 | PF01048 | 0.759 |
MOD_GlcNHglycan | 9 | 12 | PF01048 | 0.559 |
MOD_GSK3_1 | 106 | 113 | PF00069 | 0.411 |
MOD_GSK3_1 | 193 | 200 | PF00069 | 0.411 |
MOD_GSK3_1 | 234 | 241 | PF00069 | 0.378 |
MOD_GSK3_1 | 304 | 311 | PF00069 | 0.397 |
MOD_GSK3_1 | 334 | 341 | PF00069 | 0.312 |
MOD_GSK3_1 | 358 | 365 | PF00069 | 0.777 |
MOD_GSK3_1 | 420 | 427 | PF00069 | 0.777 |
MOD_N-GLC_1 | 4 | 9 | PF02516 | 0.583 |
MOD_NEK2_1 | 100 | 105 | PF00069 | 0.280 |
MOD_NEK2_1 | 197 | 202 | PF00069 | 0.411 |
MOD_NEK2_2 | 85 | 90 | PF00069 | 0.402 |
MOD_PIKK_1 | 446 | 452 | PF00454 | 0.828 |
MOD_PK_1 | 373 | 379 | PF00069 | 0.706 |
MOD_PKA_1 | 373 | 379 | PF00069 | 0.706 |
MOD_PKA_1 | 49 | 55 | PF00069 | 0.411 |
MOD_PKA_1 | 78 | 84 | PF00069 | 0.402 |
MOD_PKA_2 | 202 | 208 | PF00069 | 0.436 |
MOD_PKA_2 | 420 | 426 | PF00069 | 0.657 |
MOD_PKA_2 | 49 | 55 | PF00069 | 0.390 |
MOD_PKA_2 | 69 | 75 | PF00069 | 0.378 |
MOD_PKA_2 | 78 | 84 | PF00069 | 0.318 |
MOD_Plk_1 | 398 | 404 | PF00069 | 0.733 |
MOD_Plk_1 | 4 | 10 | PF00069 | 0.584 |
MOD_Plk_4 | 193 | 199 | PF00069 | 0.411 |
MOD_Plk_4 | 338 | 344 | PF00069 | 0.397 |
MOD_Plk_4 | 398 | 404 | PF00069 | 0.756 |
MOD_Plk_4 | 458 | 464 | PF00069 | 0.723 |
MOD_ProDKin_1 | 110 | 116 | PF00069 | 0.411 |
MOD_ProDKin_1 | 235 | 241 | PF00069 | 0.471 |
MOD_ProDKin_1 | 310 | 316 | PF00069 | 0.280 |
MOD_ProDKin_1 | 358 | 364 | PF00069 | 0.767 |
MOD_SUMO_for_1 | 150 | 153 | PF00179 | 0.411 |
TRG_ER_diArg_1 | 198 | 201 | PF00400 | 0.397 |
TRG_ER_diArg_1 | 202 | 204 | PF00400 | 0.411 |
TRG_ER_diArg_1 | 286 | 288 | PF00400 | 0.411 |
TRG_ER_diArg_1 | 320 | 322 | PF00400 | 0.386 |
TRG_ER_diArg_1 | 331 | 333 | PF00400 | 0.397 |
TRG_ER_diArg_1 | 463 | 465 | PF00400 | 0.720 |
TRG_ER_diArg_1 | 66 | 68 | PF00400 | 0.411 |
TRG_NLS_Bipartite_1 | 21 | 38 | PF00514 | 0.411 |
TRG_NLS_MonoExtN_4 | 32 | 38 | PF00514 | 0.411 |
TRG_Pf-PMV_PEXEL_1 | 170 | 174 | PF00026 | 0.411 |
TRG_Pf-PMV_PEXEL_1 | 177 | 181 | PF00026 | 0.411 |
TRG_Pf-PMV_PEXEL_1 | 21 | 25 | PF00026 | 0.411 |
TRG_Pf-PMV_PEXEL_1 | 289 | 294 | PF00026 | 0.411 |
TRG_Pf-PMV_PEXEL_1 | 464 | 468 | PF00026 | 0.715 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HY11 | Leptomonas seymouri | 55% | 100% |
A0A3Q8IF48 | Leishmania donovani | 90% | 100% |
A4HHD4 | Leishmania braziliensis | 75% | 100% |
A4I4H9 | Leishmania infantum | 90% | 100% |
E9ALV1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 100% |